- This innovative public-private partnership will establish an evidence-based model to boost capacity development for health systems initially in Dubai, to be scaled up in Asia-Pacific, Middle East, and North Africa in phases
- Through this collaboration between the Dubai Academic Health Corporation, AXDEV Global and Pfizer Global Medical Grants, Dubai will serve as a testbed to plan and implement the model in four health centers
- Diabetes will be used as a case example to apply and measure the impact of the interventions to be scaled to other chronic illnesses
Dubai, United Arab Emirates March 22, 2023 – The Dubai Academic Health Corporation, AXDEV Global, and Pfizer Global announced a public-private partnership to enhance care for patients diagnosed with chronic illnesses, supported by an independent grant from Pfizer Global Medical Grants. The goal of the collaboration is to establish an evidence-based model in performance and quality improvement to support the adoption of best practices and boost capacity development for patient care with chronic illnesses at the individual, team, practice, and health systems levels.
Dubai will serve as a testbed to plan and implement the model, identified as the ideal city for the research given its diverse cultural population and unwavering support of its academic health system, the Dubai Academic Health Corporation. The findings will then be scaled to enhance chronic illness care in low- and middle-income countries (LMICs) in Asia-Pacific, the Middle East, and North Africa. The Dubai Academic Health Corporation will host the initiative at its medical university, Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), and AXDEV will provide expert implementation research & project management across every step of the program. All activities are supported by Pfizer’s independent grant including the research, development, and execution of medical education activities, toolkits and implementation science across multiple health centres in Dubai.
Through a research project out of MBRU, the research will take diabetes as a case example to apply and measure the impact of the interventions in four local health centres in Dubai. Today, diabetes is a chronic illness that affects almost one in every five adults in the United Arab Emirates and is one of the leading causes of kidney failure globally. The evidence and results gathered in Dubai will then be scaled to LMICs to reorganize chronic illness care and provide critical tools and education for clinicians, allied health professionals, staff and healthcare administrators.
Commenting on the importance of public-private partnerships, Dr. Hanan Alsuwaidi, Chief Business Officer of the Dubai Academic Health Corporation, shared, “The healthcare industry has experienced significant changes since the pandemic. World-class healthcare systems are now turning to proficient partnerships to reimagine business models and access new capabilities. Public-private partnerships, like this one between the Dubai Academic Health Corporation, AXDEV and Pfizer, leverage the strength of all its members to accelerate the adoption of best practices in patient care.”
Suzanne Murray, Founder and CEO of AXDEV Group adds, “This public private collaboration, that will bring cutting edge education solutions for healthcare professionals and their teams to directly impact clinical practice, is a testimony that three major organizations, as well as the health centres involved, are committed to improve patient health outcomes with evidence based and quality education and implementation research.”
Yasser El Dershaby, Vice President, MERA Regional Cluster Medical Lead, Pfizer, also commented on the importance of health equity, “Accessible healthcare for patients living with chronic illnesses is critical given that they are tethered to the healthcare system. Especially in LMICs, it has always been Pfizer’s goal to enhance health equity in underserved communities. Our new public-private partnership with The Dubai Academic Health Corporation and AXDEV Global brings us one step closer to bridging these gaps, and I look forward to the results from our initial research in Dubai.”
About Dubai Academic Health Corporation
The Dubai Academic Health Corporation aims to advance health services in Dubai through a new academic system that integrates healthcare, medical education, and scientific research. The Corporation aims to improve the efficiency, quality, and accessibility of Dubai’s healthcare services in accordance with the highest standards and best practices. It will also seek to strengthen Dubai’s leadership in academic education and scientific research in the fields of medicine and health sciences, as part of the broader strategy to strengthen the knowledge economy. The establishment of the Dubai Academic Health Corporation will contribute to strengthening Dubai’s position as a global hub for medical and life sciences and a leading center for medical education, research, and scientific innovation.
About AXDEV Global
AXDEV is a leading performance improvement organization that specialises in assisting healthcare systems and stakeholders improve professional competencies, interdisciplinary team practices, systems functioning, and clinical practice efficiency and performance.
AXDEV has 25 years of experience in education, performance improvement, public-private collaborations, research, and solutions designed and conducted for healthcare systems (hospitals, outpatient community care, government, and corporate health systems). Our specific focus is on the assessment of human behaviours, professional competencies, and performance at the individual, team, and systems level.
AXDEV has also performed as expert consultants in the design, development and operationalization of Education and Performance Improvement Strategies.
AXDEV has over 50 peer-reviewed publications in international clinical and educational journals and has received numerous awards in the field of continuing education and performance improvement.
AXDEV is supported by a team of experts in behavioural sciences, organizational development, marketing/management, educational, clinical and industrial psychology. Our team provides international healthcare markets the evidence and performance solutions that drive successful results for a better healthcare environment.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.